INTUITIVE SURGICAL INC (IUI1.DE) Stock Price, Quote, News and Overview
FRA:IUI1 - Deutsche Boerse Ag - US46120E6023 - Common Stock - Currency: EUR
IUI1.DE Quote, Performance and Key Statistics
FRA:IUI1 (8/8/2025, 7:00:00 PM)
402.85
+2.65 (+0.66%)
The current stock price of IUI1.DE is 402.85 EUR. In the past month the price decreased by -8.08%. In the past year, price decreased by -4.93%.
IUI1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.2 | 199.21B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 58.33 | 143.64B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 36.54 | 131.38B | ||
| 2M6.DE | MEDTRONIC PLC | 16.7 | 100.99B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.51 | 52.37B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.12 | 46.06B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 30.13 | 39.06B | ||
| DC4.DE | DEXCOM INC | 45.99 | 26.33B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.97 | 22.15B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.92 | 22.08B | ||
| 1STMN.MI | STRAUMANN HOLDING AG-REG | 37.46 | 17.38B | ||
| QS51.DE | STRAUMANN HOLDING AG-REG | 36.79 | 17.07B |
Related stock screener links
About IUI1.DE
Company Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company Info
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 14085232100
INTUITIVE SURGICAL INC / IUI1.DE FAQ
What is the stock price of INTUITIVE SURGICAL INC today?
The current stock price of IUI1.DE is 402.85 EUR. The price increased by 0.66% in the last trading session.
What is the ticker symbol for INTUITIVE SURGICAL INC stock?
The exchange symbol of INTUITIVE SURGICAL INC is IUI1 and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is IUI1.DE stock listed?
IUI1.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for INTUITIVE SURGICAL INC stock?
40 analysts have analysed IUI1.DE and the average price target is 518.46 EUR. This implies a price increase of 28.7% is expected in the next year compared to the current price of 402.85. Check the INTUITIVE SURGICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INTUITIVE SURGICAL INC worth?
INTUITIVE SURGICAL INC (IUI1.DE) has a market capitalization of 144.41B EUR. This makes IUI1.DE a Large Cap stock.
How many employees does INTUITIVE SURGICAL INC have?
INTUITIVE SURGICAL INC (IUI1.DE) currently has 15638 employees.
What are the support and resistance levels for INTUITIVE SURGICAL INC (IUI1.DE) stock?
INTUITIVE SURGICAL INC (IUI1.DE) has a support level at 402.84 and a resistance level at 418.95. Check the full technical report for a detailed analysis of IUI1.DE support and resistance levels.
Is INTUITIVE SURGICAL INC (IUI1.DE) expected to grow?
The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 19.56% in the next year. Check the estimates tab for more information on the IUI1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INTUITIVE SURGICAL INC (IUI1.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IUI1.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IUI1.DE, evaluating the profitability, health, valuation and growth aspects
- INTUITIVE SURGICAL INC (IUI1.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INTUITIVE SURGICAL INC (IUI1.DE) Sales and EPS estimates to see what analysts future expectations are.
- INTUITIVE SURGICAL INC (IUI1.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INTUITIVE SURGICAL INC (IUI1.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- INTUITIVE SURGICAL INC (IUI1.DE) Stock Chart to make your own analysis
- INTUITIVE SURGICAL INC (IUI1.DE) Latest news and press-releases to stay up to date.
Does INTUITIVE SURGICAL INC (IUI1.DE) stock pay dividends?
IUI1.DE does not pay a dividend.
When does INTUITIVE SURGICAL INC (IUI1.DE) report earnings?
INTUITIVE SURGICAL INC (IUI1.DE) will report earnings on 2025-10-15, after the market close.
What is the Price/Earnings (PE) ratio of INTUITIVE SURGICAL INC (IUI1.DE)?
The PE ratio for INTUITIVE SURGICAL INC (IUI1.DE) is 58.3. This is based on the reported non-GAAP earnings per share of 6.91 and the current share price of 402.85 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IUI1.DE.
IUI1.DE Technical Analysis
IUI1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to IUI1.DE. IUI1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
IUI1.DE Financial Highlights
Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 6.91. The EPS increased by 26.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.51% | ||
| ROA | 12.93% | ||
| ROE | 14.52% | ||
| Debt/Equity | 0 |
IUI1.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to IUI1.DE. The Buy consensus is the average rating of analysts ratings from 40 analysts.
For the next year, analysts expect an EPS growth of 9.11% and a revenue growth 19.56% for IUI1.DE